Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 19 is a nonfunctional nuclear pseudogene related to the mitochondrial NADH dehydrogenase 4 gene (MT-ND4). Unlike the bona fide mitochondrial MT-ND4 gene, which encodes a core subunit of Complex I in the mitochondrial respiratory chain, MT-ND4 pseudogenes are nuclear sequences derived from ancient mitochondrial gene insertions (NUMTs) and do not encode functional proteins. These pseudogenes may contain mutations, insertions, or premature stop codons that prevent protein translation. They are sometimes amplified in molecular genetic assays but do not contribute to mitochondrial function or disease pathogenesis[6]. If you are looking for the real therapeutic target, search for “MT-ND4” or “NADH-ubiquinone oxidoreductase chain 4”; MTND4P19 is not a genuine target or protein but a genomic relic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 19 (MTND4P19).